Effect of Hyponatremia in Small Cell Lung Cancer

Frequency and Effect on the Prognosis of Hyponatremia During the diagnosıs in Small Cell Lung Cancer

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04451460

Enrollment

466

Registered

2020-06-30

Start date

2012-01-01

Completion date

2017-01-01

Last updated

2020-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Small Cell Lung Cancer

Keywords

Small cell lung cancer, hyponatremia, prognosis, treatment, biochemistry

Brief summary

In this retrospective study, the investigators determined the frequency of hyponatremia in small cell lung cancer and the prognosis. 126 (27%) of 466 patients were hyponatremic. Hyponatremia could not be corrected in 50.8% (n=64) of hyponatremic patients. Survival was found to be better in the group of whom hyponatremia was corrected.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Patients diagnosed with SCLC between January 2012 and January 2017 in our hospital were retrospectively screened

Exclusion criteria

Over 18 age If data doesn't exist

Design outcomes

Primary

Measure	Time frame	Description
Mortality	Through study completion, an average of 3 months	Effect of hyponatremia according to mortality

Outcome results